Halla Sigma Valley 442-2
Floor L2 Sangdaewon-dong Joongwon-gu
Seongnam-si
South Korea
82 2 561 4011
https://en.aprogen-pharm.com/index.do
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Jeong-Chool Kim | Chief Executive Officer | N/A | N/A | N/A |
Mr. Jung-Chul Kim | President | N/A | N/A | N/A |
Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics. Aprogen Biologics Inc. was founded in 1960 and is headquartered in Seongnam-si, South Korea.
El ISS Governance QualityScore de Aprogen Biologics Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.